title: Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction.
authors.affiliation: Royal Victoria Hospital, McGill University Health Center, Montréal, Québec, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Cantarovich
authors.forename: M
authors.initials: M
authors.lastname: Quantz
authors.forename: E
authors.initials: E
authors.lastname: Elstein
authors.forename: P
authors.initials: P
authors.lastname: Ergina
authors.forename: C
authors.initials: C
authors.lastname: Magnan
authors.forename: B
authors.initials: B
authors.lastname: de Varennes
mesh_terms: D000208:Acute Disease; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D009202:Cardiomyopathies / Q000601:surgery; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D008775:Methylprednisolone